February 17, 2021 – Vizient, Inc. (Irving, TX) announced the publication of its High-Value Pharmacy Enterprise Project, a report produced by health
care organization pharmacy leaders who participate in the Vizient Pharmacy Network. The full report, a combination of literature review, consensus statements and performance recommendations, addresses clinical services and business services such as cost management, revenue integrity and business growth as well as makes technology recommendations.
Vizient says the High-Value Pharmacy Enterprise Project (HVPE) report is an important resource for health system pharmacy leaders and C-suite executives that identifies areas of published research of statistically significant improvement in patient outcomes in pharmacy services and roles.
The HVPE report is a follow up to “Strategic approach for improving the medication-use process in health systems: The high-performance pharmacy practice framework,” published in 2007.
The report calls on pharmacy enterprises to demonstrate their value to individual patient outcomes, population health, and the overall success, including financial success, of their health system.
Through eight key domains, the report addresses an expansive list of topics, including:
- Patient care services in the ambulatory, specialty pharmacy and inpatient settings
- Safety and quality
- Pharmacy workforce
- Information technology including data analytics and information management
- Business practices